Medication Evaluation of Oral Antidiabetic Agents in Hospitalized Patients with Type-2 Diabetes at National Hospital in Dili
Abstract
Among several types of diabetes mellitus (DM), type-2 DM seemed to demonstrate the highest prevalence. Appropriate management in type-2 DM should follow rational use of antidiabetic agents to prevent any unfavorable impacts. In fact, due to the limited guidelines and medication resources, medication process for patients with type-2 DM has not been evaluated in Timor-Leste, especially at a national hospital in Dili. This was the first study which aimed to evaluate the use of oral antidiabetic agents (OAD) in hospitalized patients with type-2 DM at a national hospital, Dili Timor-Leste.
This study was conducted retrospectively under cross-sectional design to describe the rational drug use evaluation based on indicators: right patient, right dose, right indication, right drug, and cautious to adverse events according to guideline from American Diabetes Association (2020). The included patients were diagnosed as type-2 DM, hospitalized during year 2020, and received OAD. Data were calculated (%) for each indicator of rational drug use.
A total number of 83 hospitalized patients with type-2 DM at a national hospital in Dili had taken metformin (62.65%), gliclazide (12.15%), and combination of both metformin and gliclazide (22.89%), respectively. The evaluation results of OAD use according to ADA guideline comprised of right indication 100%, right patient 100%, right drug 72.28%, right dose 100%, and cautious to adverse events 93.7%. Despite favorable results in rational medication, enhancement for limitation of OAD use at a national hospital in Dili, Timor-Leste is compulsory.
References
Tjay TH, Rahardja K. Obat-Obat Penting. 7th ed. Jakarta: PT. Elex Media Komputindo; 2015.
International Diabetes Federation. IDF diabetes atlas, 9th edn. Brussels, Belgium: International Diabetes Federation; 2019.
Perkumpulan Endokrinologi Indonesia. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. Jakarta: Pengurus Besar Perkumpulan Endokrinologi Indonesia; 2019.
Kementerian Kesehatan Republik Indonesia. Modul Penggunaan Obat Rasional. Jakarta: Bina Pelayanan Kefarmasian; 2011.
Keban SA, Ramdhani UA. Hubungan rasionalitas pengobatan dan self-care dengan pengendalian glukosa darah pada pasien rawat jalan di Rumah Sakit Bina Husada Cibinong. JIfI. 2016;14(1):66-72.
Selly AG. Rasionalitas Penggunaan Obat Antidiabetes pada Pasien DM Tipe 2 Rawat Inap di RSUD Prof. Dr. W. Z. Johannes Kupang Periode 2018 [Skripsi]. Kupang: Universitas Citra Bangsa; 2019.
Hongdiyanto A, Yamlean PVY, Supriati HS. Evaluasi kerasionalan pengobatan diabetes melitus tipe 2 pada pasien rawat inap di RSUP Prof. Dr. R. D. Kandou Manado tahun 2013. Pharmacon. 2014;3(2):77-86.
Suminar R, Hasanmihardja M, Kusumawati A. Rasionalitas penggunaan antidiabetika pada pasien geriatri penderita diabetes melitus di instalasi rawat inap Rumah Sakit PKU Muhammadiyah Sruweng tahun 2010. Pharmacy: Jurnal Farmasi Indonesia. 2011;8(3):100-8.
Ministériu Saúde. Package of Essential Noncommunicable Diseases. Timor-Leste: Ministério da Saúde; 2017.
American Diabetes Association. Standar of Medical Care in Diabetes: Diabetes Care—2020. Diabetes Care. 2020;43(Supplement 1):S1-S212.
Fatimah RN. Diabetes Melitus Tipe 2. Majority. 2015;4(5):93-101.
Mildawati M, Diani N, Wahid A. Hubungan usia, jenis kelamin dan lama menderita diabetes dengan kejadian neuropati perifer diabetik. CNJ: Caring Nursing Journal. 2019;3(2):30-7.
Wilmot E, Idris I. Early onset type 2 diabetes: risk factors, clinical impact and management. Ther Adv Chronic Dis. 2014;5(6):234-44.
Morrison MA, Magalhaes TR, Ramke J, Smith SE, Ennis S, Simpson CL, et al. Ancestry of the Timorese: age-related macular degeneration associated genotype and allele sharing among human populations from throughout the world. Front Genet. 2015;6:238.
Masruroh E. Hubungan umur dan status gizi dengan kadar gula darah penderita diabetes melitus tipe II. Jurnal Ilmu Kesehatan. 2018;6(2):153-63.
Mutmainah I. Hubungan Kadar Gula Darah dengan Hipertensi pada Pasien Diabetes Melitus Tipe 2 di Rumah Sakit Umum Daerah Karanganyar [Skripsi]. Surakarta: Universitas Muhammadiyah Surakarta; 2013.
Baitanu KY. Evaluasi Terapi Obat Antidiabetik pada Pasien Geriatri dengan Diabetes Melitus Tipe 2 di Puskesmas Sikumana [Skripsi]. Kupang: Universitas Citra Bangsa; 2019.
Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380(9841):601-10.
Katzung BG, Masters SB, Trevor AJ. Basic and Clinical Pharmacology. 12th ed. New York, USA: McGraw-Hill Companies; 2012.
Ningrum VDA, Ikawati Z, Sadewa AH, Ikhsan MR, Yunilistiaingsih Y. Faktor pasien yang mempengaruhi respon glikemik penggunaan monoterapi metformin pada diabetes melitus tipe 2. JMPF. 2016;6(4):261-9.
King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999;48(5):643-8.
Kisrini, Ediningsih E, Suyatmi, Sudarsono J, Maftuhah A, Randita ABT, et al. Buku Pedoman Keterampilan Klinis: Keterampilan Penulisan Resep (Prescription). Surakarta: Universitas Sebelas Maret Surakarta; 2018.
Sultan MT, Sultan NA, Sultan SRA, Sultan RB, Sultan ABK. A study on rational drug prescribing pattern in geriatric patients in Hyderabad metropolitan. JDDT. 2012;2(5):109-13.
Dewi EU. Gambaran faktor-faktor yang mempengaruhi terkendalinya kadar gula darah pada pasien diabetes melitus di Puskesmas Pakis Surabaya. Jurnal Keperawatan. 2015;4(2).
Djamaludin M. Pengantar Farmakologi. Jakarta: Rajawali Press; 2017.
Ministériu Saúde. Lista Medikamentus Esensial. Timor-Leste: Ministério da Saúde; 2015.
Sari EN, Perwitasari DA. Rasionalitas pengobatan diabetes melitus tipe 2 di RSUP Dr. Sardjito dan RS PKU Muhammadiyah Yogyakarta. Farmasains: Jurnal Ilmu Kefarmasian. 2013;2(2):66-70.
Harjo EY. Evaluasi Rasionalitas Pengobatan Diabetes Mellitus Tipe 2 pada Pasien Rawat Jalan di Puskesmas Kampung Bali Kota Pontianak Periode Januari-Desember 2015 [Skripsi]. Pontianak: Universitas Tanjungpura; 2016.
Decroli E. Diabetes Melitus Tipe 2. 1st ed. Padang: Pusat Penerbitan Bagian Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Andalas; 2019.
Sola D, Rossi L, Schianca GP, Maffioli P, Bigliocca M, Mella R, et al. Sulfonylureas and their use in clinical practice. Arch Med Sci. 2015;11(4):840-8.
Mariyono HH, Suryana K. Adverse Drug Reaction. J Peny Dalam. 2008;9(2):164-72.
Aberg J, Lacy CF, Amstrong LL, Goldman MP, Lance L. Drug Information Handbook. USA: Lexi-Comp for the American Pharmacists Association; 2008.
Sebayang LB, Marbun RAT, Kartika D. Efektivitas kerasionalan pemberian antidiabetik pengobatan oral pasien diabetes mellitus pada usia 30-50 tahun tipe 2 rawat inap penyakit dalam RSUD Deli Serdang Lubuk Pakam tahun 2020. Jurnal Farmasimed (JFM). 2021;3(2):74-80.
Ramdini DA, Wahidah LK, Atika D. Evaluasi Rasionalitas Penggunaan Obat Diabetes Melitus Tipe II pada Pasien Rawat Jalan di Puskesmas Pasir Sakti Tahun 2019. Jurnal Farmasi Lampung. 2020;9(1):67-76.
Nurfauzi Y, Rahmawati F, Yasin NM, Wahyono D. Penilaian Kebutuhan Home Pharmacy Care untuk Pasien Diabetes Mellitus Tipe 2 yang Disertai Hipertensi pada Usia Lanjut. Jurnal Farmasi Indonesia. 2020;17(1):63-77.
